GPATCH2 Human Pre-designed siRNA Set A
GPATCH2 Human Pre-designed siRNA Set A contains three designed siRNAs for GPATCH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
GPATCH2 Human Pre-designed siRNA Set A contains three designed siRNAs for GPATCH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
GPATCH2 siRNA-1: 5 nmol (HPLC)
GPATCH2 siRNA-2: 5 nmol (HPLC)
GPATCH2 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Gene ID
Gene Information
GPATCH2 - G-patch domain containing 2 Gene (Human)
Also Known as
Pfa1; CT110; GPATC2; PPP1R30
Chemical Information
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
RNA interference technology
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing gene transcription or activating RNA degradation. This mechanism was discovered in plants in 1998 by Andrew Fire and Craig Mello. Today, this phenomenon can be observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals.
Pureté et documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)